Safety and Efficacy Study of Lithium in Bipolar Disorder

Status unconfirmed · Phase 3

Conditions studied: Bipolar Disorder, Mania

In brief

The purpose of this study is to determine whether Lithium is safe and effective in the treatment of Bipolar I Disorder subjects with symptoms of acute mania.

Key facts

Study ID

NCT00422331

Run by

JDS Pharmaceuticals

People needed

206

Starts

2007-01-01

Expected to finish

2007-12-01

Last updated by the study team

2007-08-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Bipolar 1 Disorder;
• Hospitalized or in the process of being hospitalized for a manic or mixed episode

You may not qualify if…

• History of rapid cycling;
• History of hypersensitivity or adverse reaction to lithium

Where it is running

• JDS Pharmaceuticals — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.